New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System™
18 avr. 2024 08h00 HE
|
Noah Medical
New Field Data Shows High Diagnostic Yield for Lung Biopsy Diagnosis Using the Galaxy System™
Lung Cancer Screening Market To Reach USD 3.2 Billion By 2032
12 déc. 2023 07h00 HE
|
DataHorizzon Research
Fort Collins, Colorado, Dec. 12, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, The Lung Cancer Screening Market size was valued at USD 1.4 Billion in 2022 and is expected to reach a...
Lung Cancer Screening Market to Hit USD 5.13 Billion by 2030 on Account of Rising Incidence of Lung Cancer and Advancements in Screening Technologies | Research by SNS Insider
26 sept. 2023 08h52 HE
|
SNS Insider pvt ltd
Pune, Sept. 26, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report indicates that in 2022, the Lung Cancer Screening Market had a valuation of USD 2.81 billion. It is projected to achieve a value of...
8.2% CAGR for Lung Cancer Screening Market Worth $4.36Bn by 2030 with NSCLC Segment (8% CAGR) Driving Growth During 2022-2030 | The Insight Partners
06 juil. 2023 10h08 HE
|
The Insight Partners
Pune, India, July 06, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Lung Cancer Screening Market Size Report and Forecast to 2030 - COVID-19 Impact and...
Hepatitis E Diagnostic Tests Market to Reach $93.5 Million by 2031: Says AMR
13 déc. 2022 02h20 HE
|
Allied Market Research
Portland, OR, Dec. 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Hepatitis E Diagnostic Tests Market was estimated at $61.7 million in 2021 and...
Lung Cancer Screening Market to Reach USD 4.85 Billion by 2028; Medtronic Acquires Koninklijke Philips N.V to Bolster its Global Position: Fortune Business Insight™
30 août 2021 05h45 HE
|
Fortune Business Insights
Pune, India, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The global lung cancer screening market size was USD 2.61 billion in 2020. The market is projected to grow from USD 2.80 billion in 2021 to USD 4.85...
VisionGate Lung Cancer 3D Cellular Imaging Research to be Featured as a Late-Breaking Abstract at the AACR Annual Meeting 2018
12 avr. 2018 13h46 HE
|
VisionGate, Inc.
SEATTLE, WA, April 12, 2018 (GLOBE NEWSWIRE) -- VisionGate, Inc., a clinical stage oncology pharmaceutical and diagnostics company, is pleased to announce that new lung cancer 3D cellular imaging...
Vital Further Streamlines Lung Screening Workflow with Support of Nuance PowerScribe® 360 and PenRad™ PenLung™
12 sept. 2016 09h52 HE
|
Vital Images, Inc.
MINNEAPOLIS, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Vital Images, Inc. (Vital), a Minneapolis-based advanced medical imaging and informatics company, is pleased to announce the support of Nuance...
Study finds 43 percent of patients undergoing lung cancer screening experience elevated levels of distress
19 oct. 2015 18h04 HE
|
American College of Chest Physicians
GLENVIEW, Ill., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Low-dose computed tomography (LDCT) lung cancer screening is recommended to screen patients with an increased risk of developing lung cancer, but...